ArticleFrontiers in cardiovascular medicine2026
Comprehensive angiographic evaluation of graft quality after endoscopic vein harvesting in coronary artery bypass grafting.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- OPCAB in the minimally invasive era: impact on wound complications-a comparative study with on-pump CABG.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The saphenous vein graft (SVG) remains a mainstay conduit for coronary artery bypass grafting (CABG) due to its accessibility and length. Although the no-touch technique may improve long-term patency, wound complications are a continuing concern. Since 2011, our institution has adopted endoscopic vein harvesting (EVH) as the standard approach. This study provides angiographic insights into graft quality and patency after EVH compared with open vein harvesting (OVH), with additional assessment of mid-term clinical outcomes. Methods: Among 471 patients who underwent CABG between 2005 and 2017, 307 were included in this study. Patients were divided into the EVH group (Group A, Results: Angiographic assessment demonstrated comparable SVG patency between the EVH and OVH groups (93% vs. 94%), with similar rates of anastomotic stenosis (2.2% vs. 2.3%) and severe graft stenosis (≥90%; 1.5% vs. 1.2%). No significant differences were observed in 30-day mortality (1.5% vs. 3.5%), in-hospital mortality (1.5% vs. 2.1%), or postoperative stroke. Wound-related complications were rare, including wound dehiscence (1.5% vs. 2.3%) and infection (0.7% vs. 1.2%). MACCE-free survival rates at 1, 3, and 5 years were 97%, 94%, and 91% in the EVH group vs. 92%, 86%, and 76% in the OVH group, respectively ( Conclusion: Detailed angiographic evaluation revealed that EVH did not compromise graft quality or patency compared with conventional OVH. The incidence of wound complications was very low, and early postoperative SVG-related events were favorable. These findings suggest that EVH is a safe and reliable harvesting technique, providing high-quality grafts with excellent angiographic integrity. Individualized selection of harvesting strategy remains important for optimizing surgical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.